Dr. Carolina Ilkow
C3 IMPACT Lead
C3 IMPACT-OV
Senior Scientist, Cancer Therapeutics Program
Ottawa Hospital Research Institute
Associate Professor, Department of Biochemistry, Microbiology and Immunology
University of Ottawa
Dr. Ilkow is an Associate Professor at the University of Ottawa and an early-career researcher at the Ottawa Hospital Research Institute. Her research focuses on innovative biotherapeutics for cancer treatment, such as oncolytic viruses and exosome-based therapies. She has published 22 peer-reviewed articles and filed three patents in the past five years, with a strong collaborative approach involving leading experts in the cancer immunotherapy field. Dr. Ilkow is a huge proponent for training the next generation of researchers and plays a key role in the CanPRIME training program which trains HQP in the Canadian biotherapeutics sector. Her goal is to make a positive impact on cancer treatment and offer lasting hopeto patients and their families.